ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Tlando: Another Oral Testosterone Undecanoate OK'd for Hypogonadism
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 220489" data-attributes="member: 3"><p><h2>FDA approval of Tlando follows in the footsteps of Jatenzo</h2><p></p><p>The recommended dosage is 225 mg orally twice daily with food. It does not require dose titration.</p><p></p><p>"We believe Tlando's oral formulation and convenient dosing, which requires no titration, differentiates it from other treatment options," noted Apple.</p><p></p><p>The drug was also deemed a Schedule III controlled substance, due to risks of abuse and misuse of testosterone.</p><p></p><p>Tlando joins an already lengthy list of testosterone treatments, the vast majority of which are injectable or topical. This approval most closely follows the <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-oral-testosterone-capsule-treatment-men-certain-forms-hypogonadism" target="_blank">2019 approval</a> of Clarus Therapeutics' own version of oral testosterone undecanoate marketed under the trade name Jatenzo.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 220489, member: 3"] [HEADING=1]FDA approval of Tlando follows in the footsteps of Jatenzo[/HEADING] The recommended dosage is 225 mg orally twice daily with food. It does not require dose titration. "We believe Tlando's oral formulation and convenient dosing, which requires no titration, differentiates it from other treatment options," noted Apple. The drug was also deemed a Schedule III controlled substance, due to risks of abuse and misuse of testosterone. Tlando joins an already lengthy list of testosterone treatments, the vast majority of which are injectable or topical. This approval most closely follows the [URL='https://www.fda.gov/news-events/press-announcements/fda-approves-new-oral-testosterone-capsule-treatment-men-certain-forms-hypogonadism']2019 approval[/URL] of Clarus Therapeutics' own version of oral testosterone undecanoate marketed under the trade name Jatenzo. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
Tlando: Another Oral Testosterone Undecanoate OK'd for Hypogonadism
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top